CanadaDrugstore.com: Your Pharmaceuticals Resource - Page 2

Pharmacists navigate complex insurance rules requiring patients to try generic drugs before brand-name ones. Learn how prior authorization works, why it delays care, and what strategies actually work to get approvals faster.

IVIVC lets pharmaceutical companies replace costly human bioequivalence trials with lab-based dissolution tests. Learn how this science works, why most submissions fail, and when it’s the right choice for generic drug approval.

Learn how to safely store high-risk medications like opioids and benzodiazepines to prevent accidental overdoses in homes. Simple steps, real data, and practical solutions for families.

AREDS2 vitamins are proven to slow vision loss in intermediate AMD but don't help early AMD or prevent the disease. Learn who should take them, what's in the formula, and the latest 2024 findings on late-stage AMD.

Isoniazid is vital for treating tuberculosis but carries a high risk of liver damage, especially when combined with rifampin or in slow acetylators. Learn how genetics, drug interactions, and monitoring affect safety.

Autoimmune hepatitis is a chronic liver disease where the immune system attacks the liver. Diagnosis relies on blood tests and biopsy. Steroids and azathioprine are the standard treatment, effectively controlling inflammation and preventing liver damage in most patients.

Medication-induced hair loss is common and often reversible. Learn which drugs cause it, how long it lasts, and what treatments actually work-from minoxidil to scalp cooling and nutritional support.

Bone turnover markers like PINP and β-CTX-I provide early insight into how well osteoporosis treatments are working-often within weeks, not years. Learn how they guide smarter, faster care.

Most clinicians don't know how much drugs cost - and that gap is harming patient health. Learn why price awareness matters, how EHR tools are helping, and what needs to change to make prescribing both effective and affordable.

Generic drugs save money-but their availability and price vary wildly across countries. Why do the same pills cost 10x more in some places? Here’s how global policies, manufacturing, and regulation shape access.